Moreover, the combination of anti-PD-1 and IU1 effectively increased the Granzyme B+CD8+/Tregs ratio in the tumor mass, which is characteristic of successful ICB-based therapy36 (Fig. 6l). This evidence concerns the gene PDCD1 and neoplasm.